Clinical Trial Update: Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial results update for sorafenib in patients with extensive-stage or recurrent small cell lung cancer; the study is completed and results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• Nexavar (Sorafenib)
• Sorafenib (Sorafenib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Extensive Stage Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-09-19